INTERCEPT PHARMACEUTICALS, INC. (28) | Business Finance (10)

Browse by Subcategory

Recent Contracts

Form of Stock Option Grant Notice and Agreement for Directors (Filed With SEC on August 10, 2020)
Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,... (Filed With SEC on May 14, 2019)
Securities Purchase Agreement, dated May 8, 2019, between Intercept Pharmaceuticals, Inc. and Samsara BioCapital, L.P (Filed With SEC on May 14, 2019)
Second Supplemental Indenture, dated as of May 14, 2019, between Intercept Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee (including the form of 2.00%... (Filed With SEC on May 14, 2019)
Form of Restricted Stock Unit Award Grant Notice and Agreement for Directors (Filed With SEC on August 10, 2020)
Form of Restricted Stock Unit Award Grant Notice and Agreement for Employees and Consultants (Filed With SEC on February 25, 2020)
Form of Stock Option Grant Notice and Agreement for Employees and Consultants (Filed With SEC on February 25, 2020)
Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies... (Filed With SEC on May 14, 2019)
Form of Stock Option Grant Notice and Agreement for Employees and Consultants (Filed With SEC on May 8, 2019)
Form of Restricted Stock Unit Grant Notice and Agreement for Employees and Consultants (Filed With SEC on May 8, 2019)